Cover image of the article: Erratum: The Effectiveness and Safety of Rhomboid Intercostal Block for Postoperative Pain Management in Thoracic and Breast Surgical Procedures: A Meta-analysis [Anesth Pain Med. 2024;14(5):e150753] (AI-generated illustration)

Image Credit:AI-generated illustration

Erratum: The Effectiveness and Safety of Rhomboid Intercostal Block for Postoperative Pain Management in Thoracic and Breast Surgical Procedures: A Meta-analysis [Anesth Pain Med. 2024;14(5):e150753]

Authors

Taufik SaputraTaufik Saputra ORCID1,*, Doso SutiyonoDoso Sutiyono ORCID2, Widya Istanto NurcahyoWidya Istanto Nurcahyo ORCID2
How to Cite:Saputra T, Sutiyono D, Istanto Nurcahyo W. Erratum: The Effectiveness and Safety of Rhomboid Intercostal Block for Postoperative Pain Management in Thoracic and Breast Surgical Procedures: A Meta-analysis [Anesth Pain Med. 2024;14(5):e150753]. Anesth Pain Med. 2026;16(4):e176915. doi: https://doi.org/10.5812/aapm-176915

Dear Readers,
We sincerely apologize to the readers of Anesthesiology and Pain Medicine for an error in our article entitled “The Effectiveness and Safety of Rhomboid Intercostal Block for Postoperative Pain Management in Thoracic and Breast Surgical Procedures: A Meta-analysis,” published in Anesth Pain Med. 2024;14(5):e150753 (1). We are writing to correct two statements in Section 4.6.1 (Overall 24 h Post-surgery Opioid Consumption) of the Results that do not describe the analysis that was actually performed.
The article pooled randomized controlled trials to evaluate the effectiveness and safety of the rhomboid intercostal block (RIB) for postoperative pain management after thoracic and breast surgical procedures. One of its outcomes was postoperative opioid consumption, and Section 4.6.1 reports the pooled 24-hour opioid consumption in patients who received RIB compared with controls. In the included trials, opioid consumption was recorded as fentanyl in two studies and as morphine, tramadol, and sufentanil in one study each. As described in the same section, the morphine, tramadol, and sufentanil doses were converted to fentanyl equivalents before pooling.
However, the published text incorrectly states that the study using sufentanil was excluded from the analysis and that only four studies were analyzed. These statements are not correct. The 24-hour opioid consumption analysis included all five randomized controlled trials, with 368 patients (184 in each of the RIB and control groups), including the study that used sufentanil. The patient numbers given in the same paragraph and in Table 2 (368 patients from five randomized controlled trials) already correspond to this five-study analysis. The incorrect statements were remnants of an earlier draft of the manuscript and were not removed before publication. Because the published wording implies that one trial was removed from the pooled estimate, readers could misinterpret the number of studies and patients on which the reported reduction in 24-hour opioid consumption is based. The pooled result was in fact calculated from all five trials and is reported correctly in the article.
The text of Section 4.6.1 should therefore be corrected as follows.
In Section 4.6.1, the following sentence should be deleted:
“However, the study using sufentanil was excluded from the analysis as its converted fentanyl dose was significantly lower than in the other groups, which could skew the results.”
In Section 4.6.1, the following sentence:
“Across the four remaining studies, 368 patients were included, with 184 in both the RIB and control groups.”
should read:
“Across the five included studies, 368 patients were included, with 184 in both the RIB and control groups.”
This correction concerns the text only. The analyzed data, the pooled estimate (SMD = -4.49; 95% CI: -6.09 to -2.90; P < 0.00001; I² = 95%), and the conclusions of the article remain unchanged, and no other section of the article is affected.
We regret any confusion this error may have caused and thank the readers and the editorial office of the journal for their understanding.
Yours sincerely,
Taufik Saputra
Faculty of Medicine, Diponegoro University, Semarang, Indonesia

References

  • 1.
    Saputra T, Sutiyono D, Nurcahyo WI. The effectiveness and safety of rhomboid intercostal block for postoperative pain management in thoracic and breast surgical procedures: A meta-analysis. Anesth Pain Med. 2024;14(5). e150753. [PubMed ID: 40689104]. [PubMed Central ID: PMC12275635]. https://doi.org/10.5812/aapm-150753.

Copyright

Copyright © 2026, Saputra et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Similar Articles

17
Jan
2015

Corrigendum to: Comparing the Effects of Morphine Sulfate and Diclofenac Suppositories on Postoperative Pain in Coronary Artery Bypass Graft Patients (published in a Oct 30, 2014; Anesthesiology and Pain Medicine. 4(4): e19423, DOI: 10.5812/aapm.19423

Valiollah Hassani

Hassani V. Corrigendum to: Comparing the Effects of Morphine Sulfate and Diclofenac Suppositories on Postoperative Pain in Coronary Artery Bypass Graft Patients (published in a Oct 30, 2014; Anesthesiology and Pain Medicine. 4(4): e19423, DOI: 10.5812/aapm.19423. Anesth Pain Med. 2015;5(1):e61533. doi: https://doi.org/10.5812/aapm.25875

8
Jul
2026

Retracted: Magnesium Gargle Versus Ketamine Gargle in Postoperative Sore Throat Pain; A Randomized Placebo-Controlled Clinical Trial [J Cell Mol Anesth. 2020;5(3): e149598]

Houman Teymourian,
Nima Saeedi,
Gholamreza Mohseni,
Shayesteh Khorasanizadeh,
Nastaran Hajizade

Teymourian H, Saeedi N, Mohseni G, Khorasanizadeh S, Hajizade N. Retracted: Magnesium Gargle Versus Ketamine Gargle in Postoperative Sore Throat Pain; A Randomized Placebo-Controlled Clinical Trial [J Cell Mol Anesth. 2020;5(3): e149598]. J Cell Mol Anesth. 2020;5(3):e149598. doi: https://doi.org/10.22037/jcma.v5i3.29471

13
Feb
2014

Corrigendum to: Is Fasting Duration Important in Post Adenotonsillectomy Feeding Time? [Published in Anesth Pain Med. 2014 January; 3(3): e10256]

Seyedhejazi Mahin

Mahin S. Corrigendum to: Is Fasting Duration Important in Post Adenotonsillectomy Feeding Time? [Published in Anesth Pain Med. 2014 January; 3(3): e10256]. Anesth Pain Med. 2014;4(1):e74471. doi: https://doi.org/10.5812/aapm.18021

31
Oct
2026
Correction: Pain Reduction and Patient-Reported Mobility Satisfaction Following Ultrasound-Guided Stellate Ganglion Block in Complex Regional Pain Syndrome Type I: A Retrospective Longitudinal Cohort Study (AI-generated illustration)

Correction: Pain Reduction and Patient-Reported Mobility Satisfaction Following Ultrasound-Guided Stellate Ganglion Block in Complex Regional Pain Syndrome Type I: A Retrospective Longitudinal Cohort Study

Aliakbar Nasiri,
Ahmadreza Afshar,
Mohammad Mahdi Abdollahi

Nasiri A, Afshar A, Abdollahi MM. Correction: Pain Reduction and Patient-Reported Mobility Satisfaction Following Ultrasound-Guided Stellate Ganglion Block in Complex Regional Pain Syndrome Type I: A Retrospective Longitudinal Cohort Study. Arch Neurosci. 2026;13(4):e176429. doi: https://doi.org/10.5812/ans-176429

22
Oct
2021

Retraction Note: Effect of Perioperative Intravenous Lignocaine Infusion on Haemodynamic Responses and postoperative Analgesia in Laparoscopic Cholecystectomy Surgeries

Krishna Murthy TK,
Vinay Kumar PV

TK KM, Kumar PV V. Retraction Note: Effect of Perioperative Intravenous Lignocaine Infusion on Haemodynamic Responses and postoperative Analgesia in Laparoscopic Cholecystectomy Surgeries. Anesth Pain Med. 2021;11(5):e120608. doi: https://doi.org/10.5812/aapm.120608

More by these authors

Taufik SaputraPubMedScholar
Doso SutiyonoPubMedScholar
Widya Istanto NurcahyoPubMedScholar
Share
Cited by
Metrics